SCHEMBL14628656

SCHEMBL14628656

COc1cccc2[nH]c3c(c12)C(C(N)=O)CC3

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.45
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 6/20 0.44
HSD17B10 Q99714 4/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 1/20 0.43
HTR2C P28335 3/20 0.41
SIRT1 Q96EB6 2/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
PARP1 P09874 1/20 0.39
HTR2A P28223 1/20 0.37
HTR2B P41595 1/20 0.37
PIN1 Q13526 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
MAPK10 P53779 1/20 0.36
RIPK1 Q13546 1/20 0.36
EP300 Q09472 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14598623 0.88 MAPKAPK2 (0.45) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL14628657 0.85 DDB1 (0.39) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL14628606 0.83 PLA2G2A (0.38) KDM4EALDH1A1HSD17B10HPGDSIRT1
SCHEMBL14628655 0.82 SIRT1 (0.44) KDM4EALDH1A1MAPTSIRT1PARP1
SCHEMBL16585852 0.81 MAPKAPK2 (0.43) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL14628605 0.80 MAPKAPK2 (0.43) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL14628604 0.78 HTR2C (0.43) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL14628611 0.77 HTR2C (0.42) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL14628610 0.75 MAPKAPK2 (0.41) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL14628631 0.74 HTR2C (0.42) MAPKAPK2KDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7160909-B2 Cyclopenta[b]indole derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 2007-01-09 US disclosed